Pharmacokinetics of MP-3180 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Glomerular Filtration RateAcute Kidney Injury
Interventions
DRUG

MP-3180

MP-3180 (1 µmol/kg or 0.372 mg/kg) (fluorescent tracer agent) was administered by IV injection (2.5 mL to 3.5 mL for participant weights of 70 kg to 91 kg) over 2 minutes, followed by a 10 mL saline flush IV over 2 minutes.

OTHER

Iohexol comparator

Iohexol (Omnipaque 300, 5 mL) was administered by IV injection over 2 minutes, followed by a 10 mL saline flush IV over 2 minutes.

Trial Locations (1)

21201

University of Maryland, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MediBeacon

INDUSTRY